9-137192572-TTCCTCCTCCTCCTCCTCC-TTCCTCCTCCTCCTCC
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001128228.3(TPRN):βc.1842_1844delβ(p.Glu621del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00237 in 1,564,720 control chromosomes in the GnomAD database, including 14 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.0058 ( 5 hom., cov: 33)
Exomes π: 0.0020 ( 9 hom. )
Consequence
TPRN
NM_001128228.3 inframe_deletion
NM_001128228.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.164
Genes affected
TPRN (HGNC:26894): (taperin) This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-137192572-TTCC-T is Benign according to our data. Variant chr9-137192572-TTCC-T is described in ClinVar as [Benign]. Clinvar id is 165579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-137192572-TTCC-T is described in Lovd as [Benign]. Variant chr9-137192572-TTCC-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00577 (873/151212) while in subpopulation AFR AF= 0.0173 (714/41244). AF 95% confidence interval is 0.0163. There are 5 homozygotes in gnomad4. There are 422 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPRN | NM_001128228.3 | c.1842_1844del | p.Glu621del | inframe_deletion | 2/4 | ENST00000409012.6 | NP_001121700.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPRN | ENST00000409012.6 | c.1842_1844del | p.Glu621del | inframe_deletion | 2/4 | 1 | NM_001128228.3 | ENSP00000387100 | P1 | |
TPRN | ENST00000477345.1 | n.2563_2565del | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
TPRN | ENST00000333046.8 | c.1236_1238del | p.Glu419del | inframe_deletion | 2/3 | 2 | ENSP00000327617 |
Frequencies
GnomAD3 genomes AF: 0.00578 AC: 873AN: 151102Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
873
AN:
151102
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00610 AC: 1280AN: 209928Hom.: 1 AF XY: 0.00600 AC XY: 683AN XY: 113872
GnomAD3 exomes
AF:
AC:
1280
AN:
209928
Hom.:
AF XY:
AC XY:
683
AN XY:
113872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00200 AC: 2832AN: 1413508Hom.: 9 AF XY: 0.00215 AC XY: 1507AN XY: 701808
GnomAD4 exome
AF:
AC:
2832
AN:
1413508
Hom.:
AF XY:
AC XY:
1507
AN XY:
701808
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00577 AC: 873AN: 151212Hom.: 5 Cov.: 33 AF XY: 0.00571 AC XY: 422AN XY: 73880
GnomAD4 genome
AF:
AC:
873
AN:
151212
Hom.:
Cov.:
33
AF XY:
AC XY:
422
AN XY:
73880
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 15, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 11, 2013 | Glu621del in Exon 2 of TPRN: This variant is not expected to have clinical signi ficance because it has been identified in 5.7% (455/8007) of European American c hromosomes and 6.5% (264/4126) of African American chromosomes by the NHLBI Exom e Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs77086130 ). - |
Autosomal recessive nonsyndromic hearing loss 79 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at